A Study to Test Long-term Safety of Iclepertin in People With Schizophrenia Who Took Part in a Previous CONNEX Study

NCT05211947 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

1356

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Iclepertin

Sponsor

Boehringer Ingelheim